Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $8.18-$29.56 |
Market Cap | $645.2M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $88.3M |
Revenue Growth (YoY) | 264.3% |
Gross Profit (12 Mos) | -$182M |
Diluted EPS | -$2.60 |
News
See moreYahoo Finance • 25 days ago
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • 2 months ago
Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright
Yahoo Finance • 2 months ago
Morgan Stanley lowers Nurix stock price target to $16 on higher spend
Yahoo Finance • 2 months ago
Goldman Sachs initiates Nurix stock with Buy rating, $182 price target
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 286 |
